AOD 9604 isnt appropriate for everyone, such as those who: Before starting, inform your prescriber if youre taking the following medication to prevent harmful drug interactions: Your licensed clinician should run baseline laboratory tests before starting your dosing, which they must always supervise
Signs your cycle length needs adjustment Extend the cycle if: you are still seeing meaningful progress at week 8, your goals require more fat loss than achieved so far, and you are not experiencing any diminishing returns or side effects
While Tirzepatide often produces greater total weight loss than AOD-9604 , it also carries a more complex side effect profile including nausea, vomiting, and gastrointestinal distress
However, its important to note that 24 weeks, while substantial for clinical trials, represents a relatively limited timeframe for assessing lifetime exposure safety
The pharmacokinetic barrier has recently been overcome with the synthesis of the orally active, blood-brain barrierpermeable analog N-hexanoic-tyrosine-isoleucine-(6) aminohexanoic amide (dihexa)